Risk Factors for Coronary Heart Disease Among Lebanese Women: A Case-Control Study

Fatima Ghaddar1, Rouba K Zeidan2,3,4,5, Pascale Salameh4,6,7,8

  • 1Doctoral School of Biology Health and Biotechnologies, Toulouse University, Toulouse, France.

Insights

Coronary heart disease risk factors in Lebanese women over forty were identified. Post-menopausal women showed higher risks from dyslipidemia, hypertension, and smoking, necessitating targeted prevention strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Women's Health

Background:

  • Coronary heart disease (CHD) presents unique risk factors in women.
  • Understanding these specific risks is crucial for effective prevention.

Purpose of the Study:

  • To assess the risk factors for coronary heart disease (CHD) in Lebanese women over forty.
  • To identify differences in risk factors between pre- and post-menopausal women.

Main Methods:

  • A case-control study involving 1500 women (300 cases, 1200 controls) in Beirut and Mount-Lebanon.
  • Data collected via interviews and hospital records, analyzed using binary logistic regression.
  • Participants stratified into pre- and post-menopausal groups.

Main Results:

  • In post-menopausal women, CHD was associated with dyslipidemia, hypertension, family history of CHD, smoking, and joint pain.
  • Protective factors included living in Mount Lebanon, moderate income, Mediterranean diet, and physical activity.
  • In pre-menopausal women, dyslipidemia, hypertension, and family history of dyslipidemia/CHD were significant risk factors.

Conclusions:

  • CHD risk factors in women, especially post-menopause, require specific attention.
  • Highlights the need for tailored CHD prevention strategies for women.
  • Emphasizes the importance of addressing modifiable risk factors like diet and physical activity.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
82
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
48
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
85
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
51
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
46
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
125